For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230907:nRSG7643La&default-theme=true
RNS Number : 7643L Eco Animal Health Group PLC 07 September 2023
7 September 2023
ECO Animal Health Group plc ("the Company")
(AIM: EAH)
Result of Annual General Meeting
ECO Animal Health Group plc announces that at its Annual General Meeting held
earlier today ("AGM") all resolutions proposed to the meeting were duly
passed.
Proxy votes received in relation to each resolution were as follows:
Resolution For Against Withheld
% Discretionary % %
01 40,393,039 1,594 Nil
99.996 Nil 0.000 0.004
02 37,377,701 3,013,548 Nil
92.531 3,384 0.008 7.460
03 40,386,195 8,187 251
99.979 Nil 0.000 0.020
04 40,393,039 1,594 Nil
99.996 Nil 0.000 0.004
05 40,392,788 1,594 251
99.995 Nil 0.000 0.004
06 40,383,756 5,877 5,000
99.973 Nil 0.000 0.014
07 40,383,756 5,877 5,000
99.973 Nil 0.000 0.014
Contacts:
ECO Animal Health Group plc 020 8447 8899
David Hallas (Chief Executive Officer)
Christopher Wilks (Chief Financial Officer)
IFC Advisory 020 3934 6630
Graham Herring
Zach Cohen
Singer Capital Markets (Nominated Adviser & Joint Broker)
Philip Davies 020 7496 3000
George Tzimas
Sam Butcher
Investec (Joint Broker)
Gary Clarence 020 7597 5970
Carlo Spingardi
Lydia Zychowska
Equity Development 020 7065 2692
Hannah Crowe
Matt Evans
About ECO Animal Health
ECO Animal Health Group plc ("ECO" or "the "GROUP") researches, develops and
commercialises products for livestock. Our business strategy is to generate
shareholder value by achieving the maximum sales potential from the existing
product portfolio whilst investing in Research and Development ("R&D") for
new products, particularly vaccines, and seeking to in-license new products.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END RAGSSMFDWEDSEIU